Cathie Wood Sarepta Therapeutics, Inc. Transaction History

Ark Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$65.97 - $92.48 $33.3 Million - $46.7 Million	-504,442 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$69.38 - $86.75 $94.1 Million - $118 Million	-1,355,851 Reduced 72.88%	504,442 $39.2 Million
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $117 Million - $273 Million	1,617,382 Added 665.83%	1,860,293 $139 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $30.5 Million - $43.4 Million	242,911 New	242,911 $41.4 Million
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$112.21 - $151.95 $0 - $0	0 New	0 $0
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $267,101 - $379,806	-2,504 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$97.32 - $148.76 $243,689 - $372,495	2,504 New	2,504 $273,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.